Edition:
United States

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.41USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
256,283
52-wk High
$4.07
52-wk Low
$1.33

Chart for

About

Organovo Holdings, Inc. is an early commercial-stage company focused on developing and commercializing functional human tissues. The Company focuses on the generation of three-dimensional (3D) human tissues, by utilizing its platform technology to create human tissue constructs in 3D. It is focused on development of products,... (more)

Overall

Beta: 3.08
Market Cap(Mil.): $150.76
Shares Outstanding(Mil.): 106.92
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Organovo posts Q3 loss per share $0.09

* Organovo announces fiscal second-quarter 2018 results; company shifts commercial focus to higher-value disease modeling opportunities and updates full-year fiscal 2018 outlook

Nov 09 2017

BRIEF-Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

* Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease

Nov 06 2017

BRIEF-Organovo reports Q1 loss per share $0.10

* Organovo announces fiscal first-quarter 2018 results; company affirms full-year fiscal 2018 outlook

Aug 09 2017

Earnings vs. Estimates